Concurrent epirubicin and trastuzumab use increases complete pathological response rate without additional cardiotoxicity in patients with human epidermal growth factor receptor 2‐... by Ming‐Han Yang, Chiun‐Sheng Huang, Dwan‐Ying Chang, Fu‐Chang Hu, Shu‐Min Huang, Po‐Hsiang Huang, I‐Chun Chen, Tom Wei‐Wu Chen, Ching‐Hung Lin, Yen‐Shen Lu

Get full text

Part I: consensus statements and expert recommendations for HER2-negative early breast cancer in the Asia-Pacific region: diagnosis and risk assessment by Soo Chin Lee, Yeon Hee Park, Christian F. Singer, Judith Balmaña, Rebecca Alexandra Dent, Veronique Kiak-Mien Tan, Nadia Ayu Mulansari, Mastura Md Yusof, Frances Victoria F. Que, Yen-Shen Lu, Napa Parinyanitikul, Cam Phuong Pham, Nur Aishah Taib, Sun-Young Kong, Yoland Antill, Yoland Antill, Hee Jeong Kim

Get full text

Capivasertib plus fulvestrant in patients with HR-positive/HER2-negative advanced breast cancer: phase 3 CAPItello-291 study extended Chinese cohort by Xichun Hu, Qingyuan Zhang, Tao Sun, Huihua Xiong, Wei Li, Yuee Teng, Yen-Shen Lu, Ling-Ming Tseng, Min Yan, Hongsheng Li, Danmei Pang, Shin-Cheh -Chen, Wenyan Chen, Ou Jiang, Jingfen Wang, Xinhong Wu, Xian Wang, Aimin Zang, Xiaojia Wang, Julie M. Collins, Ethan Fan, Lin Jiang, Xiaoling Zeng, Nicholas C. Turner

Get full text

Part II: consensus statements and expert recommendations for BRCA-associated breast cancer in the Asia-Pacific region: clinical management by Yeon Hee Park, Soo Chin Lee, Christian F. Singer, Judith Balmaña, Rebecca Alexandra Dent, Veronique Kiak-Mien Tan, Nadia Ayu Mulansari, Mastura Md. Yusof, Frances Victoria F. Que, Yen-Shen Lu, Napa Parinyanitikul, Cam Phuong Pham, Cam Phuong Pham, Cam Phuong Pham, Nur Aishah Taib, Sun-Young Kong, Yoland Antill, Yoland Antill, Hee Jeong Kim

Get full text